Literature DB >> 33179714

Nine-year, single-centre experience of left atrial appendage occlusion: patient characteristics, procedural outcomes and long-term follow up.

Mark Abelson1, Andre Phillips2, Shirley Middlemost3.   

Abstract

This is a review of 114 patients with atrial fibrillation who had left atrial appendage occlusion with an Amplatzer cardiac plug over a nine-year period done by a single operator. This shows that the procedure can be safely performed with a very low rate of major complications (< 1%) and a zero procedural mortality rate. Long-term follow up over an average of 38.5 months showed a 65% reduction in actual versus predicted stroke rate. This is similar to that seen with oral anti-coagulants and other published trials and registries involving left atrial appendage occlusion.

Entities:  

Keywords:  atrial fibrillation; left atrial appendage occlusion; Amplatzer cardiac plug ; Amulet

Mesh:

Year:  2020        PMID: 33179714      PMCID: PMC8756066          DOI: 10.5830/CVJA-2020-051

Source DB:  PubMed          Journal:  Cardiovasc J Afr        ISSN: 1015-9657            Impact factor:   1.167


  17 in total

1.  Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF).

Authors:  Leif Friberg; Niklas Hammar; Hans Pettersson; Mårten Rosenqvist
Journal:  Eur Heart J       Date:  2007-08-01       Impact factor: 29.983

2.  Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study).

Authors:  Pavel Osmancik; Petr Tousek; Dalibor Herman; Petr Neuzil; Pavel Hala; Josef Stasek; Ludek Haman; Petr Kala; Martin Poloczek; Marian Branny; Jan Chovancik; Pavel Cervinka; Jiri Holy; Vlastimil Vancura; Richard Rokyta; Milos Taborsky; Tomas Kovarnik; David Zemanek; Petr Peichl; Sarka Haskova; Jiri Jarkovsky; Petr Widimsky
Journal:  Am Heart J       Date:  2016-10-11       Impact factor: 4.749

3.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas
Journal:  Eur Heart J       Date:  2016-08-27       Impact factor: 29.983

4.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.

Authors:  E J Benjamin; P A Wolf; R B D'Agostino; H Silbershatz; W B Kannel; D Levy
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

Review 5.  Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.

Authors:  Ayodele Odutayo; Christopher X Wong; Allan J Hsiao; Sally Hopewell; Douglas G Altman; Connor A Emdin
Journal:  BMJ       Date:  2016-09-06

6.  Device-Related Thrombus After Left Atrial Appendage Closure.

Authors:  Srinivas R Dukkipati; Saibal Kar; David R Holmes; Shephal K Doshi; Vijendra Swarup; Douglas N Gibson; Brijeshwar Maini; Nicole T Gordon; Michael L Main; Vivek Y Reddy
Journal:  Circulation       Date:  2018-08-28       Impact factor: 29.690

7.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors:  David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

8.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Authors:  David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

9.  5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.

Authors:  Vivek Y Reddy; Shephal K Doshi; Saibal Kar; Douglas N Gibson; Matthew J Price; Kenneth Huber; Rodney P Horton; Maurice Buchbinder; Petr Neuzil; Nicole T Gordon; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2017-11-04       Impact factor: 24.094

10.  All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study.

Authors:  Tommy Andersson; Anders Magnuson; Ing-Liss Bryngelsson; Ole Frøbert; Karin M Henriksson; Nils Edvardsson; Dritan Poçi
Journal:  Eur Heart J       Date:  2013-01-14       Impact factor: 29.983

View more
  1 in total

1.  Can we reduce bleeding risk after interventional procedures?

Authors:  Farrel Hellig
Journal:  Cardiovasc J Afr       Date:  2021 Jan-Feb       Impact factor: 1.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.